1.15
price down icon2.54%   -0.03
after-market Handel nachbörslich: 1.15
loading

Telomir Pharmaceuticals Inc Aktie (TELO) Neueste Nachrichten

pulisher
Jun 18, 2025

TELO Rises on Promising Telomir-1 Preclinical Results - MSN

Jun 18, 2025
pulisher
Jun 18, 2025

Telomir Pharmaceuticals Prevents Cellular Aging in Patient-Derived Cells from Children with Progeriaan Ultra-Rare Genetic Disorder that Causes Rapid Aging - Knoxville News Sentinel

Jun 18, 2025
pulisher
Jun 18, 2025

# Telomir-1 shows anti-aging effects in progeria cell study By Investing.com - Investing.com South Africa

Jun 18, 2025
pulisher
Jun 18, 2025

Telomir Pharmaceuticals reports positive results for progeria treatment By Investing.com - Investing.com South Africa

Jun 18, 2025
pulisher
Jun 18, 2025

Telomir Pharmaceuticals reports positive results for progeria treatment - Investing.com

Jun 18, 2025
pulisher
Jun 18, 2025

# Telomir-1 shows anti-aging effects in progeria cell study - Investing.com Australia

Jun 18, 2025
pulisher
Jun 18, 2025

Telomir Pharmaceuticals IncTelomir-1 Significantly Increased Cell ViabilitySEC Filing - MarketScreener

Jun 18, 2025
pulisher
Jun 18, 2025

Revolutionary Progeria Treatment Shows First-Ever Cellular Aging Prevention in Children's Cells - Stock Titan

Jun 18, 2025
pulisher
Jun 18, 2025

EXCLUSIVE: Telomir Pharmaceuticals Says Preclinical Drug Candidate Prevents Premature Aging In Patient-Derived Cells From Children With Progeria - Benzinga

Jun 18, 2025
pulisher
Jun 13, 2025

10 Best Growth Stocks Under $100 to Buy Now - Insider Monkey

Jun 13, 2025
pulisher
Jun 12, 2025

Telomir Pharmaceuticals Announces Telomir-1 Demonstrates Dose-Dependent Restoration of Neurological, Liver and Kidney Functions in Preclinical Wilson's Disease Model - The Oklahoman

Jun 12, 2025
pulisher
Jun 11, 2025

Telomir-1 shows promise in reversing Wilson’s disease symptoms By Investing.com - Investing.com South Africa

Jun 11, 2025
pulisher
Jun 11, 2025

Telomir Pharmaceuticals reports promising drug trial results By Investing.com - Investing.com South Africa

Jun 11, 2025
pulisher
Jun 11, 2025

Telomir Pharmaceuticals reports promising drug trial results - Investing.com

Jun 11, 2025
pulisher
Jun 11, 2025

Telomir Pharmaceuticals Says Positive Preclinical Results For Telomir-1 In Wilson'S Disease Animal Model - MarketScreener

Jun 11, 2025
pulisher
Jun 11, 2025

Telomir-1 shows promise in reversing Wilson’s disease symptoms - Investing.com Australia

Jun 11, 2025
pulisher
Jun 11, 2025

Breakthrough Wilson's Disease Treatment Reverses Brain, Liver, and Kidney Damage in Preclinical Study - Stock Titan

Jun 11, 2025
pulisher
Jun 07, 2025

Nuveen Asset Management LLC Purchases New Shares in Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) - Defense World

Jun 07, 2025
pulisher
Jun 05, 2025

Telomir Pharmaceuticals Announces Telomir-1 Resets the Body's Epigenetic Clock, Reverses DNA Methylation, and Restores Youthful Gene Regulation in an Ultra-Rare Accelerated Aging Animal Model of Werner Syndrome - Reno Gazette Journal

Jun 05, 2025
pulisher
Jun 05, 2025

telomir pharmaceuticals reports promising preclinical results for telomir-1 By Investing.com - Investing.com South Africa

Jun 05, 2025
pulisher
Jun 05, 2025

EXCLUSIVE: Telomir Pharmaceuticals Lead Drug Shows Promising Signs In Animal Study For Rare Premature Aging Disorder - AOL.com

Jun 05, 2025
pulisher
Jun 05, 2025

Telomir Says Lead Candidate Telomir-1 Restored Gene Regulation in Animal Model of Werner Syndrome - MarketScreener

Jun 05, 2025
pulisher
Jun 05, 2025

telomir pharmaceuticals reports promising preclinical results for telomir-1 - Investing.com

Jun 05, 2025
pulisher
Jun 05, 2025

Telomir Pharmaceuticals-New Data From Preclinical Study Of Its Lead Compound, Telomir-1, In Validated Animal Model Of Werner Syndrome - marketscreener.com

Jun 05, 2025
pulisher
Jun 05, 2025

Revolutionary Anti-Aging Drug Resets Biological Clock, Reverses Multiple Aging Markers in Landmark Study - Stock Titan

Jun 05, 2025
pulisher
Jun 03, 2025

Telomir Pharmaceuticals Joins BIO Convention for Partnerships - MSN

Jun 03, 2025
pulisher
Jun 03, 2025

Telomir announces positive preclinical data for its novel oral AMD therapeutic - Ophthalmology Times

Jun 03, 2025
pulisher
Jun 03, 2025

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Increases Position in Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

Telomir Pharmaceuticals to Participate in BIO 2025 in Boston as Company Prepares for IND Submission and Advances Breakthrough Longevity Platform - Cheboygan Daily Tribune

Jun 03, 2025
pulisher
Jun 02, 2025

Telomir Pharmaceuticals To Present At BIO 2025, Eyes IND Filing For Telomir-1 - Nasdaq

Jun 02, 2025
$20.30
price down icon 0.68%
$36.37
price up icon 0.50%
$24.55
price up icon 8.53%
$97.80
price down icon 0.45%
$110.00
price up icon 1.61%
biotechnology ONC
$245.49
price up icon 0.48%
Kapitalisierung:     |  Volumen (24h):